arrow_back Back to App

Funding Research for a Universal Flu Vaccine

This bill authorizes the Director of the National Institute of Allergy and Infectious Diseases to conduct or support comprehensive research for the creation of a universal influenza vaccine or preventative. It authorizes appropriations of $200,000,000 for this purpose for each of fiscal years 2024 through 2029.
Key points
Research Funding: Authorizes $200 million annually from 2024 through 2029.
Objective: Creation of a universal influenza vaccine or preventative.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_3215
Sponsor: Sen. Markey, Edward J. [D-MA]
Process start date: 2023-11-02
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Flu Vaccine Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_3215.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-11-02.

What are the main provisions?

Key points include:

  • Research Funding: Authorizes $200 million annually from 2024 through 2029.
  • Objective: Creation of a universal influenza vaccine or preventative.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Markey, Edward J. [D-MA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

CATEGORIES

Health Public Investments